RB.L - Reckitt Benckiser Group plc

LSE - LSE Delayed Price. Currency in GBp
6,612.00
+72.00 (+1.10%)
At close: 4:35PM BST
Stock chart is not supported by your current browser
Previous Close6,540.00
Open6,540.00
Bid6,400.00 x 20000
Ask6,630.00 x 3500
Day's Range6,518.00 - 6,620.00
52 Week Range5,255.00 - 7,407.22
Volume1,041,405
Avg. Volume1,418,755
Market Cap46.75B
Beta (3Y Monthly)0.45
PE Ratio (TTM)7.20
EPS (TTM)918.90
Earnings DateFeb 8, 2018 - Feb 12, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est7,118.06
  • FTSE 100 hits new 6-month low as Brexit hopes lift sterling
    Reuters6 days ago

    FTSE 100 hits new 6-month low as Brexit hopes lift sterling

    Britain's top share index hovered near a six-month low on Wednesday as rising hopes for a Brexit deal lifted the pound, hurting the shares of big multinational companies. The FTSE 100 retreated by 1.3 percent while the pan-European STOXX 600 fell 1.6 percent as tech stocks suffered their worst day since the 2016 Brexit vote and investors became anxious about rising yields impacting equities. The top UK index fell as sterling hit a new 3-1/2 month high on reports that Britain and the European Union had made progress in negotiations over an Irish border backstop, a key hurdle in reaching a deal on Britain's planned departure from the EU in March next year.

  • Reuters26 days ago

    JAB sees acquisition opportunities in non-alcoholic beverages - Manager Magazin

    BERLIN/ZURICH (Reuters) - Privately owned investment firm JAB Holding Co, best known for stirring up the coffee industry with a string of deals, sees huge opportunities for acquisitions in the market for non-alcoholic beverages, one of its senior partners said in an interview with Germany's Manager Magazin published on Thursday.

  • Exclusive - Nestle, Unilever, Coke make bids in $4 billion-plus GSK India sale: sources
    Reuters28 days ago

    Exclusive - Nestle, Unilever, Coke make bids in $4 billion-plus GSK India sale: sources

    Nestle (NESN.S), Unilever (ULVR.L) (UNc.AS) and Coca-Cola (KO.N) are among bidders for GlaxoSmithKline's (GSK.L) Indian Horlicks nutrition business, expected to fetch more than $4 billion (3.03 billion pounds), four people familiar with the matter said. It was not clear which other companies were bidding, although Reckitt Benckiser (RB.L), a company eager to build up its consumer health operation, did not make an offer, two sources said. GSK, Nestle, Reckitt and Unilever declined to comment.

  • Reuterslast month

    Drugmaker Aspen sells baby milk business to dairy giant Lactalis

    Aspen Pharmacare (APNJ.J) has agreed to sell its infant formula business to Lactalis for 12.9 billion rand (660.64 million pounds) to focus on core activities while the French buyer looks to revive its baby milk expansion after a health scandal. The company's share price tumbled after the deal's announcement on Thursday alongside full-year earnings, dropping 26 percent before paring losses to stand 16.3 percent down at 228.06 rand by 1430 GMT. Rising incomes in emerging markets coupled with global population growth have made infant formula an attractive proposition in a market dominated by Nestle (NESN.S), Danone (DANO.PA) and Reckitt Benckiser (RB.L), which acquired Mead Johnson of the United States last year.

  • Reuters2 months ago

    FTSE hits 2-week low after sterling rise

    Britain's top share index fell to a two-week low on Thursday as pressure from a firmer pound hit the index's dollar-earning constituents, though utilities were a relative bright spot. The FTSE 100 (.FTSE) index was down 0.6 percent at 7,516.03 at its close, extending the previous session's losses, while mid caps (.FTMC) were also down 0.2 percent. More cyclical sectors, such as miners and financials, were the biggest weight on the index, while large, dollar-earning stocks such as British American Tobacco (BATS.L), Reckitt Benckiser (RB.L) and Diageo (DGE.L) fell 0.4 percent to 1.5 percent.

  • Reuters2 months ago

    Energy stocks prop up FTSE in cautious trade

    By Kit Rees LONDON (Reuters) - Britain's top share index edged higher on Wednesday in cautious trade as investors kept an eye on U.S.-China trade talks and politics in Washington, while heavyweight energy ...

  • Reuters2 months ago

    FTSE reverses on weak dollar and BHP Billiton

    By Helen Reid LONDON (Reuters) - Britain's top share index retreated on Tuesday as investors as a weak U.S. dollar weighed on multinational stocks and results from BHP Billiton disappointed. U.S. President ...

  • Reuters2 months ago

    GSK seeks mid-Sept bids for $4 billion Indian Horlicks unit -sources

    GlaxoSmithKline (GSK.L) is seeking initial bids by mid-September for its India-focused Horlicks health nutrition business, which is expected to fetch more than $4 billion (£3.1 billion), two people familiar with the situation said on Tuesday. The British drugmaker started a strategic review of Horlicks - a malt-based drink brand popular in India – and some smaller products, after buying Novartis (NOVN.S) out of their consumer healthcare venture for $13 billion (£10.2 billion) in March. Potential acquirers are likely to include major food and consumer products groups, such as Nestle (NESN.S), Pepsico (PEP.O) and Reckitt Benckiser (RB.L), the sources said.

  • Reuters2 months ago

    GSK seeks mid-Sept bids for $4 bln Indian Horlicks unit -sources

    GlaxoSmithKline is seeking initial bids by mid-September for its India-focused Horlicks health nutrition business, which is expected to fetch more than $4 billion, two people familiar with the situation said on Tuesday. The British drugmaker started a strategic review of Horlicks - a malt-based drink brand popular in India – and some smaller products, after buying Novartis out of their consumer healthcare venture for $13 billion in March. Potential acquirers are likely to include major food and consumer products groups, such as Nestle, Pepsico and Reckitt Benckiser, the sources said.

  • Should Income Investors Buy Reckitt Benckiser Group plc (LON:RB.) Before Its Ex-Dividend?
    Simply Wall St.2 months ago

    Should Income Investors Buy Reckitt Benckiser Group plc (LON:RB.) Before Its Ex-Dividend?

    On the 27 September 2018, Reckitt Benckiser Group plc (LON:RB.) will be paying shareholders an upcoming dividend amount of UK£0.70 per share. However, investors must have bought the company’s stockRead More...

  • Stock investors rediscover defensives before trade war deadlines
    Reuters2 months ago

    Stock investors rediscover defensives before trade war deadlines

    The risk of trade barriers and slowing global business activity has kept the European equity market in check this year. After over a year of neglect, fund managers began in the second quarter to pour money back into firms such as yoghurt maker Danone (DANO.PA), food giant Nestle (NESN.S), drugmakers Novartis (NOVN.S) and Roche (ROG.S), as well as tobacco giant BAT (BATS.L) and the maker of Durex condoms Reckitt Benckiser (RB.L). Morgan Stanley estimates a full-blown trade war would wipe 0.8 percentage points off global GDP growth.

  • U.S. joins lawsuits against Indivior, Reckitt over drug Suboxone
    Reuters2 months ago

    U.S. joins lawsuits against Indivior, Reckitt over drug Suboxone

    The Justice Department in filings last week in federal court in Abingdon, Virginia, said it was intervening in four separate whistleblower lawsuits related to the Britain-based companies' marketing of Suboxone and the related drug Subutex. The action came after Indivior, which was spun out of Reckitt in 2014, said last month it was in "advanced discussions" with the Justice Department to resolve an investigation dating back to 2013 related to its marketing practices.

  • Reuters2 months ago

    U.S. joins lawsuits against Indivior, Reckitt over drug Suboxone

    The U.S. Justice Department has joined several whistleblower lawsuits against Indivior Plc and Reckitt Benckiser Group PLC, alleging that the drugmakers improperly marketed the opioid addiction treatment Suboxone. The Justice Department in filings last week in federal court in Abingdon, Virginia, said it was intervening in four separate whistleblower lawsuits related to the Britain-based companies' marketing of Suboxone and the related drug Subutex. The action came after Indivior, which was spun out of Reckitt in 2014, said last month it was in "advanced discussions" with the Justice Department to resolve an investigation dating back to 2013 related to its marketing practices.

  • Reuters3 months ago

    Split concerns force Durex to recall some condoms in UK and Ireland

    Durex, owned by Reckitt Benckiser, has recalled some batches of its "Real Feel" and "Latex Free" condoms in the United Kingdom and Ireland due to concerns they may burst. "Our tests have shown that some batches which are currently on the market in UK & Ireland do not pass the requirements for burst pressure towards the end of the shelf life for the product," Durex said in a statement. Durex said only a limited number of batches were affected and that customers would be offered a full refund.

  • Reuters3 months ago

    Split concerns force Durex to recall some condoms in UK and Ireland

    Durex, owned by Reckitt Benckiser, has recalled some batches of its "Real Feel" and "Latex Free" condoms in the United Kingdom and Ireland due to concerns they may burst. "Our tests have shown that some batches which are currently on the market in UK & Ireland do not pass the requirements for burst pressure towards the end of the shelf life for the product," Durex said in a statement. Durex said only a limited number of batches were affected and that customers would be offered a full refund.

  • Thomson Reuters StreetEvents3 months ago

    Edited Transcript of RB.L earnings conference call or presentation 27-Jul-18 9:00am GMT

    Half Year 2018 Reckitt Benckiser Group PLC Earnings Call

  • Reckitt rally boosts FTSE
    Reuters3 months ago

    Reckitt rally boosts FTSE

    The UK's top share index advanced on Friday and posted its third week of gains as shares in consumer giant Reckitt Benckiser jumped after results and an easing of trade tensions soothed the broader market. The blue chip FTSE 100 (.FTSE) index was up 0.5 percent at 7,701.31 points at its close, joining in a rise across the broader European equity market. Heavyweight consumer staples stock Reckitt Benckiser (RB.L) was the biggest single contributor to gains as its shares jumped more than seven percent.

  • ‘Beautiful’ Sex Rates a Higher Condom Price, Reckitt CEO Says
    Bloomberg3 months ago

    ‘Beautiful’ Sex Rates a Higher Condom Price, Reckitt CEO Says

    “A beautiful sexual experience should cost 100 pounds,” Reckitt Benckiser Group Plc Chief Executive Officer Rakesh Kapoor said in jest in a conversation about the pricing potential for Durex condoms at a media event in London. Kapoor said he tells Durex employees that the products are underpriced by a factor of 10. Durex is a brand in Reckitt Benckiser’s consumer health-care division.

  • Reckitt lifts full-year revenue target as Mead Johnson deal pays off
    Reuters3 months ago

    Reckitt lifts full-year revenue target as Mead Johnson deal pays off

    The maker of Durex condoms and Lysol disinfectant raised its annual net revenue growth expectations to between 14 to 15 percent, higher than its previous target of 13 to 14 percent. Full year like-for-like sales growth is also expected to come in at the higher end of its 2 to 3 percent range, Reckitt said, as it also signalled a recovery at its Scholl footcare brand, which has struggled for the last two years. The company said its infant and child nutrition division, the acquired Mead Johnson business, was experiencing strong growth above medium-term expectations, led by China, the world's largest market for the products.

  • The Wall Street Journal3 months ago

    [$$] European Equities Market Talk Roundup

    ’s first-half results and upgraded full-year sales guidance seem to be a “decent and reassuring set of numbers,” Jefferies says. The brokerage says like-for-like sales in the second quarter were 4% ahead of market expectations as all of the company’s new divisions reported growth. The first-half margins and EPS were also “nicely ahead” of consensus, Jefferies says.

  • The Wall Street Journal3 months ago

    [$$] European Corporate Roundup for Friday

    BP’s $10.5 billion acquisition of BHP Billiton’s shale assets to boost its U.S. business is the highlight of Friday’s corporate news.